Search research articles
Contact Us
Filters
Showing results (81-90 of 111) with videos related to
Page
of 12
Sort By:
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
February 23, 2022
CAPTURE ALS: the comprehensive analysis platform to understand, remedy and eliminate ALS
Vincent Picher-Martel, Claire Magnussen, Mathieu Blais, et al.
Journal of Medical Internet Research
|
September 22, 2021
A Road Map for Remote Digital Health Technology for Motor Neuron Disease
Ruben P A van Eijk, Anita Beelen, Esther T Kruitwagen, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
February 24, 2024
The ALSFRS-R Summit: a global call to action on the use of the ALSFRS-R in ALS clinical trials
Angela Genge, Jesse M Cedarbaum, Jeremy Shefner, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
July 9, 2019
Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial
Jesus S Mora, Angela Genge, Adriano Chio, et al.
Neurology
|
March 10, 2019
Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials
Leonard H van den Berg, Eric Sorenson, Gary Gronseth, et al.
Scientific Reports
|
April 14, 2026
Speech-based digital endpoints track ALS progression and align with standard clinical outcomes: evidence from the VRG50635 trial
Michael Neumann, Hardik Kothare, Meredith Bartlett, et al.
Neuroinformatics
|
May 18, 2021
The C-BIG Repository: an Institution-Level Open Science Platform
Samir Das, Rida Abou-Haidar, Henri Rabalais, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
August 24, 2013
The CNDR: collaborating to translate new therapies for Canadians
Lawrence Korngut, Craig Campbell, Megan Johnston, et al.
The Lancet. Neurology
|
April 14, 2023
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study
James F Howard, Saskia Bresch, Angela Genge, et al.
The New England Journal of Medicine
|
September 21, 2022
Trial of Antisense Oligonucleotide Tofersen for <i>SOD1</i> ALS
Timothy M Miller, Merit E Cudkowicz, Angela Genge, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 111) with videos related to
Sort By:
Page
of 12
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
February 23, 2022
CAPTURE ALS: the comprehensive analysis platform to understand, remedy and eliminate ALS
Vincent Picher-Martel, Claire Magnussen, Mathieu Blais, et al.
Journal of Medical Internet Research
|
September 22, 2021
A Road Map for Remote Digital Health Technology for Motor Neuron Disease
Ruben P A van Eijk, Anita Beelen, Esther T Kruitwagen, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
February 24, 2024
The ALSFRS-R Summit: a global call to action on the use of the ALSFRS-R in ALS clinical trials
Angela Genge, Jesse M Cedarbaum, Jeremy Shefner, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
July 9, 2019
Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial
Jesus S Mora, Angela Genge, Adriano Chio, et al.
Neurology
|
March 10, 2019
Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials
Leonard H van den Berg, Eric Sorenson, Gary Gronseth, et al.
Scientific Reports
|
April 14, 2026
Speech-based digital endpoints track ALS progression and align with standard clinical outcomes: evidence from the VRG50635 trial
Michael Neumann, Hardik Kothare, Meredith Bartlett, et al.
Neuroinformatics
|
May 18, 2021
The C-BIG Repository: an Institution-Level Open Science Platform
Samir Das, Rida Abou-Haidar, Henri Rabalais, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
August 24, 2013
The CNDR: collaborating to translate new therapies for Canadians
Lawrence Korngut, Craig Campbell, Megan Johnston, et al.
The Lancet. Neurology
|
April 14, 2023
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study
James F Howard, Saskia Bresch, Angela Genge, et al.
The New England Journal of Medicine
|
September 21, 2022
Trial of Antisense Oligonucleotide Tofersen for <i>SOD1</i> ALS
Timothy M Miller, Merit E Cudkowicz, Angela Genge, et al.
Page
of 12